Skip to Content

Tecentriq

Generic Name: atezolizumab (A te zoe LIZ ue mab)
Brand Names: Tecentriq

Medically reviewed on June 1, 2017

What is Tecentriq?

See also: Imfinzi

Tecentriq (atezolizumab) is a monoclonal antibody that affects the actions of the body's immune system. Atezolizumab strengthens your immune system to help your body fight against tumor cells.

Tecentriq is used to treat a certain type of bladder cancer that has spread to other parts of the body or cannot be removed by surgery.

Tecentriq is also used to treat non-small cell lung cancer that has spread to other parts of the body.

Tecentriq is usually given after other cancer medicines have been tried without success.

Important information

Tecentriq strengthens your immune system to help your body fight against tumor cells. This may cause the immune system to attack normal healthy tissues or organs. When this happens, you may develop serious or life-threatening medical problems.

Call your doctor at once if you have new or worsening symptoms such as: cough, breathing problems, changes in appetite or weight, diarrhea, stomach pain, vision problems, increased thirst or urination, yellowing of the skin or eyes, mood or behavior changes, severe muscle weakness, or numbness and tingling.

Before taking this medicine

You should not use Tecentriq if you are allergic to atezolizumab.

To make sure Tecentriq is safe for you, tell your doctor if you have:

  • an active infection;

  • an immune system disorder such as lupus, ulcerative colitis, or Crohn's disease;

  • a history of organ transplant;

  • a breathing disorder;

  • liver disease; or

  • a nervous system disorder such as myasthenia gravis or Guillain BarrĂ© syndrome.

Do not use Tecentriq if you are pregnant. It could harm the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 5 months after your last dose.

It is not known whether atezolizumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using Tecentriq or within 5 months after your last dose. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.

How is Tecentriq given?

Tecentriq is injected into a vein through an IV. A healthcare provider will give you this injection.

Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.

Tecentriq is given slowly and the IV infusion can take up to 60 minutes to complete.

Tecentriq is usually given once every 3 weeks until your body no longer responds to the medication.

Tecentriq can increase your risk of infection by changing the way your immune system works. You will need frequent medical tests.

Tecentriq dosing information

Usual Adult Dose of Tecentriq for Non-Small Cell Lung Cancer:

1200 mg IV over 60 minutes every 3 weeks until disease progression or unacceptable toxicity

Comments:
-If the first infusion is tolerated, all subsequent infusions may be delivered over 30 minutes.
-Do not administer this drug as an IV push or bolus.

Uses:
-For the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy
-For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving this drug.

Usual Adult Dose of Tecentriq for Urothelial Carcinoma:

1200 mg IV over 60 minutes every 3 weeks until disease progression or unacceptable toxicity

Comments:
-If the first infusion is tolerated, all subsequent infusions may be delivered over 30 minutes.
-Do not administer this drug as an IV push or bolus.

Uses:
-For the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy
-For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving this drug.

See also: Dosage Information (in more detail)

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your Tecentriq injection.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while receiving Tecentriq?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Tecentriq side effects

Get emergency medical help if you have signs of an allergic reaction to Tecentriq: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, light-headed, chilled or feverish, itchy, or have neck pain, back pain, trouble breathing, or swelling in your face.

Call your doctor at once if you have:

  • new or worsening cough, chest pain, feeling short of breath;

  • diarrhea, bloody or tarry stools;

  • nausea or vomiting;

  • severe stomach pain (especially in your upper stomach or spreading to your back);

  • a light-headed feeling, like you might pass out;

  • blurred vision, double vision, eye pain or redness;

  • signs of infection--fever, flu symptoms, cough, painful or frequent urination;

  • liver problems - loss of appetite, drowsiness, easy bruising or bleeding, dark urine, jaundice (yellowing of the skin or eyes);

  • nervous system problems - neck stiffness, increased sensitivity to light, confusion, severe muscle weakness, numbness or tingling in your hands or feet; or

  • signs of a hormonal disorder - frequent or unusual headaches, feeling light-headed or very tired, mood or behavior changes, hoarse or deepened voice, increased hunger or thirst, increased urination, nausea, vomiting, constipation, hair loss, feeling cold, weight gain, or weight loss.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common Tecentriq side effects may include:

  • nausea, loss of appetite;

  • constipation;

  • tiredness; or

  • urination problems.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See also: Side effects (in more detail)

What other drugs will affect Tecentriq?

Other drugs may interact with atezolizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Tecentriq only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide